您当前所在的位置:首页 > 产品中心 > 产品信息
Alizapride_分子结构_CAS_59338-93-1)
点击图片或这里关闭

Alizapride

产品号 DB01425 公司名称 DrugBank
CAS号 59338-93-1 公司网站 http://www.ualberta.ca/
分子式 C16H21N5O2 电 话 (780) 492-3111
分子量 315.37024 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 1233

产品价格信息

请登录

产品别名

标题
Alizapride
IUPAC标准名
6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-2H-1,2,3-benzotriazole-5-carboxamide
IUPAC传统名
alizapride
商标名
Liticum
Limican
别名
Alizaprida [inn-spanish]
Alizapridum [inn-latin]

产品登记号

PubChem SID 46505555
CAS号 59338-93-1
PubChem CID 43008

产品性质

疏水性(logP) 1.79 [MANNHOLD,R ET AL. (1990)]

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description Alizapride is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.
Indication Alizapride is used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.
Pharmacology Alizapride is a dopamine antagonist.
Half Life 3 hours
Elimination renal
References
Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rozencweig M: Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial. Cancer Chemother Pharmacol. 1988;22(4):316-20. [Pubmed]
External Links
Wikipedia

参考文献

  • Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rozencweig M: Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial. Cancer Chemother Pharmacol. 1988;22(4):316-20. Pubmed